Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
For papers describing cancer therapies, we often look beyond conceptual advances to prioritize studies that pair strong ideas with rigorous in vivo evidence, clinically coherent models and a credible path to translation. Here, we summarize the major criteria that make cancer therapies truly stand out.
The purpose of the presubmission enquiry can be a point of confusion for our authors and can vary across journals. This month we hope to demystify its role in the editorial pipeline at Nature Biomedical Engineering.
It is an exciting time for biomedical engineering, with advances rapidly reshaping the forefront of translational research and medicine. Here we highlight some areas and technologies that we are particularly excited about for the coming years.
Although promising, gene and cell therapies can pose genotoxic risks that complicate clinical application. We describe the molecular basis of these risks, discuss tools to assess genotoxicity and highlight the advantages of non-viral genome engineering technologies for safer genome engineering.
A key aspect of biomedical advancement is improving over the state of the art. We provide guidance on our expectations for benchmarking at Nature Biomedical Engineering and encourage authors to think ahead about including crucial comparative experiments.
NotifAI-OS (notification artificial intelligence for opportunistic screening) is a conceptual deep learning-based framework that performs automated multi-target analysis of computed tomography examinations through quantitative tissue density and volumetric measurements to enable comprehensive disease screening during routine computed tomography examinations.
We take a look at how scientific articles have evolved over time and envision possible changes to how research findings are communicated in the age of digital media and artificial intelligence.
Engineer and scientist who contributed to the manipulation of single DNA molecules using electric fields, single-cell fusion and innovative integrated electronic microfluidics.
